Skip to main content
Corey Casper, MD, Infectious Disease, Seattle, WA, Fred Hutchinson Cancer Center

CoreyCasperMDMPH

Infectious Disease • Seattle, WA

Chief Executive Officer, Access to Advanced Health Institute Clinical Professor of Medicine and Global Health, University of Washington Affiliate Member, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center

Join to view full profile

Dr. Casper is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Casper's full profile

Already have an account?

Summary

  • Coronavirus treatment to begin clinical trials in Seattle

    The new treatment will focus on people already infected with coronavirus, unlike vaccines which focus on prevention.

    Seattle research institute launches fast track Covid-19 immunotherapy trial

    IDRI launches a novel immunotherapeutic Phase 1 / 2 clinical trial for the treatment of COVID-19

Education & Training

  • University of Washington
    University of WashingtonFellowship, Infectious Disease, 2000 - 2003
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1997 - 2000
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 1997

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1998 - Present
  • WA State Medical License
    WA State Medical License 2000 - 2025
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Quantitative RNAseq Analysis of Ugandan KS Tumors Reveals KSHV Gene Expression Dominated by Transcription from the LTd Downstream Latency Promoter  
    Warren Phipps, Timothy M Rose, Corey Casper, PLoS One
  • International, Evidence-Based Consensus Treatment Guidelines for Idiopathic Multicentric Castleman Disease  
    Aaron Goodman, Corey Casper, Sudipto Mukherjee, Peter Voorhees, Angela Dispenzieri, David C Fajgenbaum, Amy Chadburn, Razelle Kurzrock, Raj Jayanthan, Sunita Nasta, Th..., Blood

Abstracts/Posters

  • Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients...
    Corey Casper, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Other

Press Mentions

  • Thermostable TB Vaccine Found Safe and Immunogenic in Humans
    Thermostable TB Vaccine Found Safe and Immunogenic in HumansMarch 7th, 2023
  • The Access to Advanced Health Institute Reports Encouraging Results of First-in-Human Trial of Its Temperature-Stable Tuberculosis Vaccine Candidate
    The Access to Advanced Health Institute Reports Encouraging Results of First-in-Human Trial of Its Temperature-Stable Tuberculosis Vaccine CandidateMarch 6th, 2023
  • The Access to Advanced Health Institute Develops Longer Lasting and Broadly Protective SARS-CoV-2 RNA Vaccine Candidate That Is Stable at Room Temperature
    The Access to Advanced Health Institute Develops Longer Lasting and Broadly Protective SARS-CoV-2 RNA Vaccine Candidate That Is Stable at Room TemperatureNovember 3rd, 2022
  • Join now to see all

Hospital Affiliations

Dr. Corey Casper, Dr. Corey Casper, MD, Dr. C Casper